Alternatively, the blockade of tumor-derived factors such as IL-6, G-MCS and GM-CSF, involved in the differentiation process from GMPs/MLPGs [17,18] but also in the acquisition of suppressive features, could represent a plausible approach to limit CD15+ monocyte accumulation. The gene discussed is IL6; the disease is neoplasm.